Phase I dose-finding and pharmacologic study of cisplatin (P), irinotecan (C), and either capecitabine (X) or infusional 5-FU (F) in patients (pts) with advanced solid tumors

被引：0
|
作者：
Enzinger, Peter C. [1 ]
Earle, Craig [1 ]
Zhu, Andrew [1 ]
Blaskowsky, Lawrence [1 ]
Kulke, Matthew [1 ]
Ryan, David [1 ]
Langford, Lauren [1 ]
Michelini, Ann [1 ]
Meyerhardt, Jeffrey [1 ]
机构：
[1] Harvard Univ, Sch Med, Dana Farber Partners Canc Care, Boston, MA USA
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：106 / 106
页数：1
相关论文
共 50 条
  • [31] A phase I, dose-finding study of irinotecan (CPT-11) short i.v. infusion combined with fixed dose of 5-fluorouracil (5-FU) protracted i.v. infusion in adult patients with advanced solid tumours
    Javier Sastre
    Luis Paz-Ares
    Antonio Carcas
    Rosario Alfonso
    Cristina Grávalos
    Jesus Frías
    Pedro Guerra
    Linda Pronk
    Hernán Cortés-Funes
    Eduardo Díaz-Rubio
    Cancer Chemotherapy and Pharmacology, 2005, 55 : 453 - 460
  • [32] Clofarabine administration weekly to adult patients with advanced solid tumors in a phase I dose-finding study.
    Cunningham, CC
    Nemunaitis, J
    Senzer, N
    Vukelja, S
    Richards, D
    Vukovic, V
    Weitman, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 647S - 647S
  • [33] Phase I dose-finding and pharmacokinetic study of paclitaxel and carboplatin with oral valspodar in patients with advanced solid tumors
    Patnaik, A
    Warner, E
    Michael, M
    Egorin, MJ
    Moore, MJ
    Siu, LL
    Fracasso, PM
    Rivkin, S
    Kerr, I
    Litchman, M
    Oza, AM
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (21) : 3677 - 3689
  • [34] A PHASE I AND DOSE-FINDING STUDY OF LENVATINIB (E7080) IN JAPANESE PATIENTS WITH ADVANCED SOLID TUMORS
    Yamamoto, N.
    Nokihara, H.
    Yamada, Y.
    Honda, K.
    Wakui, H.
    Sasaki, T.
    Yusa, W.
    Tamura, T.
    ANNALS OF ONCOLOGY, 2013, 24
  • [35] Phase I dose-finding study of weekly single-agent patupilone in patients with advanced solid tumors
    Rubin, EH
    Rothermel, J
    Tesfaye, F
    Chen, TL
    Hubert, M
    Ho, YY
    Hsu, CH
    Oza, AM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (36) : 9120 - 9129
  • [36] Phase I dose-finding study of sorafenib in combination with capecitabine and cisplatin as a first-line treatment in patients with advanced gastric cancer
    Kim, Chul
    Lee, Jae-Lyun
    Choi, Yoon Hee
    Kang, Byung Woog
    Ryu, Min-Hee
    Chang, Heung Moon
    Kim, Tae Won
    Kang, Yoon-Koo
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (01) : 306 - 315
  • [37] Phase I dose-finding study of sorafenib in combination with capecitabine and cisplatin as a first-line treatment in patients with advanced gastric cancer
    Chul Kim
    Jae-Lyun Lee
    Yoon Hee Choi
    Byung Woog Kang
    Min-Hee Ryu
    Heung Moon Chang
    Tae Won Kim
    Yoon-Koo Kang
    Investigational New Drugs, 2012, 30 : 306 - 315
  • [38] Phase I dose-finding study of sorafenib in combination with capecitabine and cisplatin as a first-line treatment in patients with advanced gastric cancer
    Kim, C.
    Lee, J.
    Choi, Y.
    Kang, B.
    Ryu, M.
    Chang, H.
    Kim, T.
    Kang, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [39] Phase I dose-finding study of sorafenib in combination with capecitabine and cisplatin as a first-line treatment in patients with advanced gastric cancer
    Kim, C.
    Lee, J.
    Choi, Y.
    Kang, B.
    Ryu, M.
    Ryoo, B.
    Chang, H.
    Kim, T.
    Kang, Y.
    EJC SUPPLEMENTS, 2009, 7 (02): : 379 - 379
  • [40] Phase I study of liposome irinotecan (PEP02) in combination with weekly infusion of 5-FU/LV in advanced solid tumors
    Chen, L.
    Shiah, H.
    Chao, T.
    Hsieh, R. K.
    Chen, G.
    Chang, J.
    Yeh, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345